| scholarly article | Q13442814 |
| P50 | author | Brian Greenwood | Q4963885 |
| P2093 | author name string | Denman AM | |
| Gall D | |||
| Heath RB | |||
| Denman EJ | |||
| P2860 | cites work | QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES | Q28201512 |
| Immunosuppressive therapy. The relation between clinical response and immunologic competence | Q33461697 | ||
| The lymphocyte transformation test and gold hypersensitivity | Q33579867 | ||
| Mortality and prognosis related to the amyloidosis of Still's disease | Q33626571 | ||
| Immunological sex differences. A study of patients with rheumatoid arthritis, their relatives, and controls | Q33626674 | ||
| Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome | Q34270538 | ||
| Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis | Q35860242 | ||
| Experimental allergic encephalomyelitis: the effect of 6-mercaptopurine | Q36266009 | ||
| STUDIES ON ANTIBODY PRODUCTION. XII. INHIBITION OF PRIMING BY DRUGS | Q36266798 | ||
| Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D. | Q36268554 | ||
| Studies on the anti-inflammatory action of 6-mercaptopurine | Q36269299 | ||
| The influence of immunologically committed lymphoid cells on macrophage activity in vivo | Q36269697 | ||
| Chemical suppression of adaptive immunity | Q39964262 | ||
| Thymus and antigen-reactive cells | Q40005247 | ||
| The Thymus and the Cellular Basis of Immunity | Q40005253 | ||
| Azathioprine therapy of ?autoimmune? diseases | Q40037472 | ||
| Serological studies with Sendai virus. | Q40646716 | ||
| Enhancement of antibody formation by whole body x-radiation | Q41838340 | ||
| Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems | Q41965912 | ||
| Enhancement of antibody synthesis by 6-mercaptopurine | Q42260045 | ||
| Evaluation of immunosuppressive therapy and clinical course in renal transplants by in vitro lymphocyte transformation | Q47804890 | ||
| Azathioprine in Rheumatoid Arthritis | Q49164656 | ||
| The immune response in NZBxNZW F1 hybrid mice | Q50244355 | ||
| Apparent dissociation of antigen responsiveness and antibody production by human small lymphocytes in culture | Q50244562 | ||
| Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. | Q50245234 | ||
| Treatment of collagen diseases with cytostatics. | Q54540765 | ||
| In vitro Evaluation of Immunosuppressive Drugs | Q58975227 | ||
| Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study | Q70060500 | ||
| Lymphocyte cultures in drug hypersensitivity | Q70066608 | ||
| Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin | Q70081929 | ||
| Long-term cyclophosphamide therapy in rheumatoid arthritis | Q72046682 | ||
| Cyclophosphamide vs. conservative treatment of rheumatoid arthritis | Q72114045 | ||
| Treatment of rheumatoid polyarthritis by chlorambucil. Apropos of 48 cases | Q72356581 | ||
| Immunosuppressive Agents: The Design of Selective Therapeutic Schedules | Q72377437 | ||
| The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis | Q74282386 | ||
| SUPPRESSION OF PLASMA CELL HEPATITIS WITH 6-MERCAPTOPURINE | Q76736804 | ||
| INHIBITION OF IMMEDIATE AND DELAYED HYPERSENSITIVITY IN THE RABBIT BY 6-MERCAPTOPURINE | Q76854252 | ||
| Prognosis in Still's disease | Q78589541 | ||
| The origin of mononuclear cells in chronic inflammation and tuberculin reactions in the rat | Q95796072 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 220-231 | |
| P577 | publication date | 1970-05-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis | |
| P478 | volume | 29 |
| Q70710138 | A comparison of immunosuppressive and anti-inflammatory agents in the rat |
| Q50968350 | Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction |
| Q41066321 | Altered lymphocyte reactivity in rheumatoid arthritis |
| Q70342552 | Azathioprine in connective tissue disorders |
| Q44157159 | Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up |
| Q40286257 | Cell-mediated cytotoxicity following influenza infection and vaccination in humans |
| Q33900768 | Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection |
| Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
| Q54058552 | Cytotoxic drugs in rheumatoid arthritis. |
| Q39328565 | Drug treatment of rheumatoid arthritis. A systematic approach |
| Q90356025 | Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations |
| Q55185838 | Further Experience with Azathioprine in Rheumatoid Arthritis |
| Q33568963 | Humoral immunity in juvenille rheumatoid arthritis |
| Q72123427 | Immunological sensitisation of human lymphocytes after influenza vaccination |
| Q71650325 | Immunological studies in patients with rheumatoid arthritis receiving azathioprine and myocrisin in combination |
| Q33568525 | Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts |
| Q68918650 | Immunosuppression in the treatment of inflammatory bowel disease. I. Changes in lymphoid sub-populations in the blood and rectal mucosa following cessation of treatment with azathioprine |
| Q46198140 | Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis |
| Q39923325 | Immunosuppression — Agents, Procedures, Speculations and Prognosis |
| Q66958029 | Immunosuppressive drugs: how do they act?* |
| Q39932056 | Immunosuppressive therapy for chronic liver disease |
| Q33568597 | Impaired delayed hypersensitivity in juvenile rheumatoid arthritis |
| Q72675810 | Locus of selective depression of human natural killer cells by azathioprine |
| Q38232338 | Long-term safety of immunomodulators in pediatric inflammatory diseases |
| Q34464574 | Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans |
| Q34474161 | Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes |
| Q45883138 | Lymphocyte reactivity to influenza virus in man |
| Q66887395 | Lymphocyte response to mitogens in progressive systemic sclerosis |
| Q39434539 | Measruement of immunological function in man: interaction between virus and human leukocytes |
| Q50238131 | Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment |
| Q69141072 | New approaches to the evaluation of anti-rheumatic drugs |
| Q55038165 | Pancytopenia related to azathioprine--an enzyme deficiency caused by a common genetic polymorphism: a review |
| Q38266287 | Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases |
| Q44748228 | Phytohaemagglutinin-Induced Lymphocyte Transformation and Histologic Findings in Patients with Chronic Aggressive Hepatitis Before and During Immunosuppressive Therapy1,2) |
| Q55455212 | Rheumatoid arthritis. Surgical treatment |
| Q43948959 | Skin Testing in the Assessment of Antiinflammatory Drugs in Man |
| Q36251936 | Skin tests with influenza virus |
| Q41325839 | Studies on synovial fluid lymphocytes in rheumatoid arthritis |
| Q40857053 | The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease |
| Q70303813 | Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective |
| Q35667637 | Treatment of rheumatic disorders with special reference to ankylosing spondylitis |
| Q33551847 | Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes |
| Q38285275 | Vaccination of patients with autoimmune inflammatory rheumatic diseases |
| Q35666223 | Vaccinations in paediatric rheumatology: an update on current developments |
Search more.